First at-home test for HPV, the most common cause of cervical cancer, gains FDA approval

Published: Friday, May 9, 2025 at 6:14 pm

FDA Approves First At-Home HPV Test, Promising Easier Cervical Cancer Screening

The U.S. Food and Drug Administration (FDA) has given the green light to the first at-home screening kit for human papillomavirus (HPV), the primary cause of cervical cancer. Developed by Teal Health, the "Teal Wand" allows individuals to collect samples in the comfort of their homes and send them to a lab for analysis. This innovative approach aims to make cervical cancer screening more accessible and convenient.

The Teal Wand, currently available online in California, connects users with a healthcare provider before and after testing. A study involving over 600 participants across 16 U.S. trial sites revealed the kit's impressive accuracy, correctly detecting HPV when pre-cancerous cells were present 96% of the time. Clinicians achieved the same accuracy rate. Notably, 94% of women in the study preferred the Teal Wand over a traditional Pap smear, highlighting its potential to increase screening compliance. A significant 86% of participants indicated they would be more likely to get tested on time with the at-home kit.

The CDC reports that HPV is responsible for over 90% of cervical cancer cases in the U.S. Annually, nearly 200,000 women are diagnosed with cervical pre-cancer, and over 10,000 are diagnosed with cervical cancer, leading to approximately 4,000 deaths. The Teal Wand is approved for individuals aged 25 to 65 with an average risk of cervical cancer. It is not recommended for those with specific health conditions, including pregnancy, prior cervical cancer treatment, or a history of certain cancers or immune deficiencies. Teal Health plans to expand the kit's availability to other states soon.

BNN's Perspective: This at-home HPV test represents a significant step forward in preventative healthcare. While the convenience and potential for increased screening rates are promising, it's crucial to ensure that individuals understand the importance of follow-up care and that the test is used appropriately under the guidance of a healthcare provider. The expansion of this technology should be carefully monitored to ensure equitable access and effective integration into existing healthcare systems.

Keywords: HPV test, at-home HPV test, cervical cancer screening, Teal Wand, FDA approval, cervical cancer, HPV, women's health, Pap smear, cancer prevention, healthcare, home testing, California, pre-cancer, screening compliance, Teal Health

Full Story